Nasopharyngeal Diseases  >>  paclitaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
paclitaxel / Generic mfg.
NCT01797900: The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Completed
2
130
RoW
Cisplatin, Paclitaxel, IMRT, intensity-modulated radiotherapy
Chinese Academy of Medical Sciences
Nasopharyngeal Neoplasms
09/14
09/14
NCT01316757: Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Checkmark ASCO 2016
May 2016 - May 2016: ASCO 2016
Completed
2
24
US
cetuximab, C225, C225 monoclonal antibody, IMC-C225, MOAB C225, monoclonal antibody C225, paclitaxel, Anzatax, Asotax, TAX, Taxol, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, erlotinib hydrochloride, CP-358,774, erlotinib, OSI-774, laboratory biomarker analysis
Fox Chase Cancer Center, National Cancer Institute (NCI)
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
04/15
10/17
NCT01694576: NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation

Terminated
2
10
RoW
Adjuvant chemotherapy with paclitaxel and nedaplatin, Adjuvant chemotherapy
Jiangsu Cancer Institute & Hospital
Nasopharyngeal Carcinoma
09/15
10/15
NCT01534585: Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Completed
1/2
48
RoW
Icotinib, Conmana, intensity-modulated radiotherapy, IMRT, Paclitaxel and Cisplatin, Quality of life, QoL, Epidermal growth factor receptor status, EGFR
Taizhou Hospital
Nasopharyngeal Carcinoma
02/13
02/15
NCT01712919: Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

Completed
1/2
61
RoW
Intensity-modulated radiotherapy, Concurrent chemotherapy with paclitaxel and nedaplatin, Cetuximab
Jiangsu Cancer Institute & Hospital
Nasopharyngeal Carcinoma
03/14
03/14

Download Options